How to buy UnitedHealth Group Incorporated (UNH) stocks

UnitedHealth Group Incorporated is a healthcare plans business based in the US. UnitedHealth Group Incorporated shares (UNH) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $500.13 – a decrease of 3.91% over the previous week. UnitedHealth Group Incorporated employs 440,000 staff and has a trailing 12-month revenue of around $393.9 billion.

Our top picks for where to buy UnitedHealth Group Incorporated stock

Buy UnitedHealth Group Incorporated stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

UnitedHealth Group Incorporated stock price (NYSE: UNH)

Use our graph to track the performance of UNH stocks over time.

UnitedHealth Group Incorporated stocks at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$500.13
52-week range	$431.35 - $628.32
50-day moving average more info button	$577.69
200-day moving average more info button	$538.37
Wall St. target price	$636.05
PE ratio more info button	32.4704
Dividend yield more info button	$7.96 (1.68%)
Earnings per share (TTM) more info button	$15.39

Is it a good time to buy UnitedHealth Group Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

UnitedHealth Group Incorporated price performance over time

Historical closes compared with the close of $489.25 from 2024-12-19

1 week (2024-12-13)	-6.00%
1 month (2024-11-21)	-18.12%
3 months (2024-09-20)	-14.91%
6 months (2024-06-21)	1.38%

1 year (2023-12-21)	-5.89%
2 years (2022-12-21)	-4.39%
3 years (2021-12-21)	4.85%
5 years (2019-12-20)	79.96%

Is UnitedHealth Group Incorporated stock undervalued or overvalued?

Valuing UnitedHealth Group Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of UnitedHealth Group Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

UnitedHealth Group Incorporated's P/E ratio

UnitedHealth Group Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, UnitedHealth Group Incorporated shares trade at around 32x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

UnitedHealth Group Incorporated's PEG ratio

UnitedHealth Group Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3818. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into UnitedHealth Group Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

UnitedHealth Group Incorporated's EBITDA

UnitedHealth Group Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $35 billion.

The EBITDA is a measure of a UnitedHealth Group Incorporated's overall financial performance and is widely used to measure a its profitability.

UnitedHealth Group Incorporated financials

Revenue TTM	$393.9 billion
Operating margin TTM	8.64%
Gross profit TTM	$79.6 billion
Return on assets TTM	6.92%
Return on equity TTM	15.25%
Profit margin	3.64%
Book value	$102.42
Market Capitalization more info button	$459.9 billion

TTM: trailing 12 months

UnitedHealth Group Incorporated stock dividends

Dividend payout ratio: 30% of net profits

Recently UnitedHealth Group Incorporated has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), UnitedHealth Group Incorporated shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In UnitedHealth Group Incorporated's case, that would currently equate to about $7.96 per share.

While UnitedHealth Group Incorporated's payout ratio might seem fairly standard, it's worth remembering that UnitedHealth Group Incorporated may be investing much of the rest of its net profits in future growth.

UnitedHealth Group Incorporated's most recent dividend payout was on 16 December 2024. The latest dividend was paid out to all shareholders who bought their stocks by 8 December 2024 (the "ex-dividend date").

Have UnitedHealth Group Incorporated's stocks ever split?

UnitedHealth Group Incorporated's stocks were split on a 2:1 basis on 30 May 2005 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your UnitedHealth Group Incorporated stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for UnitedHealth Group Incorporated stocks, which in turn could have impacted UnitedHealth Group Incorporated's stock price.

UnitedHealth Group Incorporated stock price volatility

Over the last 12 months, UnitedHealth Group Incorporated's stocks have ranged in value from as little as $431.3467 up to $628.3201. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while UnitedHealth Group Incorporated's is 0.591. This would suggest that UnitedHealth Group Incorporated's stocks are less volatile than average (for this exchange).

UnitedHealth Group Incorporated overview

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of UnitedHealth Group Incorporated is owned by insiders or institutions?
Currently 0.232% of UnitedHealth Group Incorporated stocks are held by insiders and 90.17% by institutions. How many people work for UnitedHealth Group Incorporated?
Latest data suggests 440,000 work at UnitedHealth Group Incorporated. When does the fiscal year end for UnitedHealth Group Incorporated?
UnitedHealth Group Incorporated's fiscal year ends in December. Where is UnitedHealth Group Incorporated based?
UnitedHealth Group Incorporated's address is: UnitedHealth Group Center, Minnetonka, MN, United States, 55343 What is UnitedHealth Group Incorporated's ISIN number?
UnitedHealth Group Incorporated's international securities identification number is: US91324P1021 What is UnitedHealth Group Incorporated's CUSIP number?
UnitedHealth Group Incorporated's Committee on Uniform Securities Identification Procedures number is: 910581107

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.